APA (7th ed.) Citation

Mastall, M., Roth, P., Bink, A., Fischer Maranta, A., Läubli, H., Hottinger, A. F., . . . Wirsching, H. (2024). A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: The GLUGLIO trial protocol. BMC cancer, 24(1), 82-7. https://doi.org/10.1186/s12885-023-11797-z

Chicago Style (17th ed.) Citation

Mastall, Maximilian, et al. "A Phase Ib/II Randomized, Open-label Drug Repurposing Trial of Glutamate Signaling Inhibitors in Combination with Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma: The GLUGLIO Trial Protocol." BMC Cancer 24, no. 1 (2024): 82-7. https://doi.org/10.1186/s12885-023-11797-z.

MLA (9th ed.) Citation

Mastall, Maximilian, et al. "A Phase Ib/II Randomized, Open-label Drug Repurposing Trial of Glutamate Signaling Inhibitors in Combination with Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma: The GLUGLIO Trial Protocol." BMC Cancer, vol. 24, no. 1, 2024, pp. 82-7, https://doi.org/10.1186/s12885-023-11797-z.